APA (7th ed.) Citation

Su, J., He, L., & Wang, M. Post-marketing safety concerns with dolutegravir: A pharmacovigilance study based on the FDA adverse event reporting system database. Frontiers Media S.A.

Chicago Style (17th ed.) Citation

Su, Juan, Long He, and Menglei Wang. Post-marketing Safety Concerns with Dolutegravir: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System Database. Frontiers Media S.A.

MLA (9th ed.) Citation

Su, Juan, et al. Post-marketing Safety Concerns with Dolutegravir: A Pharmacovigilance Study Based on the FDA Adverse Event Reporting System Database. Frontiers Media S.A.